Internal Medicine, Endocrinology, Diabetes, & Metabolism · Cleveland, OH
NPI
1578588497
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
11100 Euclid Ave
Cleveland, OH, 44106
Phone (216) 844-8500
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
3,495 services
Medicare patients, 2024
164
Average age 71
Drug cost, 2024
$986K
1,276 prescriptions
Company payments, 2025
$3,304
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Baha M Arafah was code 99214 (office e&m - established), 135 times for 101 patients. In total Baha M Arafah billed 3,495 services in 18 codes, and Medicare paid $47K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 135 | 101 | $82.84 | $11K |
| 99215 Office E&M - Established | Office | 28 | 26 | $118.69 | $3,323 |
| 99232 Hospital E&M - Subsequent | Facility | 24 | 14 | $59.33 | $1,424 |
| 99204 Office E&M - New | Office | 20 | 20 | $107.87 | $2,157 |
| 99205 Office E&M - New | Office | 13 | 13 | $159.90 | $2,079 |
By year: 2022 $75K for 7,394 services; 2023 $110K for 5,697 services; 2024 $47K for 3,495 services.
Medicare prescription drug claims, 2024
In 2024, the drug Baha M Arafah prescribed most often to Medicare patients was Levothyroxine Sodium, with 333 prescriptions and refills. In total Baha M Arafah wrote 1,276 Medicare prescriptions that cost $986K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 333 | 844 | 104 | $3,309 |
| Hydrocortisone Generic | 166 | 356 | 48 | $9,465 |
| Synthroid Levothyroxine Sodium | 100 | 247 | 26 | $7,150 |
| Cabergoline Generic | 83 | 154 | 21 | $12K |
| Methimazole Generic | 69 | 132 | 19 | $474 |
| Calcitriol Generic | 58 | 99 | 13 | $1,039 |
| Fludrocortisone Acetate Generic | 39 | 87 | Under 11 | $572 |
| Testosterone Generic | 38 | 65 | 12 | $6,784 |
| Desmopressin Acetate Generic | 34 | 56 | Under 11 | $4,349 |
| Testosterone Cypionate Generic | 28 | 35 | Under 11 | $751 |
| Dexamethasone Generic | 22 | 44 | Under 11 | $75.7 |
| Signifor Lar Pasireotide Pamoate | 18 | 22 | Under 11 | $409K |
| Spironolactone Generic | 17 | 39 | Under 11 | $207 |
| Metformin Hcl Generic | 16 | 42 | Under 11 | $35.92 |
| Norditropin Flexpro Somatropin | 13 | 13 | Under 11 | $41K |
Brand drugs: - claims; generic drugs: 944 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Baha M Arafah $3,304 ($3,304 in general payments such as food, travel and fees) from 1 company. The largest payer was Corcept Therapeutics with $3,304.
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics CORT | 2 | $3,304 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.